Orchestrated close, forecast and gap management processes for $350M business unit. Oversaw internal controls, Treasury, and procure-to-pay activities. Developed and maintained high-performing team of engaged owners.• Owned all aspects of close and forecast, maintaining proper financial controls and ensuring accurate financial data. Presented results to leadership team, identifying risks and providing actionable recommendations to meet or surpass targets.• Fostered positive tension by challenging assumptions and methodologies. Educated business partners on financial drivers and objectives, helping to promote financial stewardship across the organization.• Co-led divestiture of underperforming business unit. Analyzed working capital and identified double-counting of several payroll liabilities, allowing Clorox to retain 5%+ of purchase price.• Managed project to move existing reports into Tableau. Utilized “proof of concept” to generate support and excitement for this new tool / capability. Shared learnings and produced roadmap for next phase of projects.• Collaborated with cross-functional leaders and Internal Audit to enhance internal controls. Addressed existing deficiencies and leveraged findings across other parts of the division.• Drove increased focus on forecast accuracy, achieving year-over-year improvement despite volume volatility. Pushed for sustainable process improvements (100+ hours / year time savings) and pursued value creation projects ($2M+ / year) to eliminate non-value-added activities and boost results.• Directed successful integration of all accounting and financial reporting activities for strategic partnerships.• Supervised team of 4-6 (2 direct reports). Optimized team to retain and promote top performers.

Guided internal start-up in strategic Chief Financial Officer-type role. Set up financial structure, processes and controls; dialogued with McKesson executives to secure support for major decisions. Managed complex inter- and intra-company transactions and relationships. Advised on mDNA roadmap including the prioritization of investments and engagements with internal business partners.• Led monthly close and forecast, annual budget and long range planning processes. Provided regular updates to mDNA leadership emphasizing variances, trends and drivers.• Partnered with project leads and business unit Finance to establish proper scoping, tracking and reporting of value for data and analytics use case services throughout the mDNA solution lifecycle.• Identified options for next fiscal year's budget when company-wide administrative cost review resulted in mandate for 50%+ reduction in planned mDNA spend.• Presented executives with breakeven analysis of scenarios under which an international mDNA headquarters would create tax advantages. Liaised with Tax, Legal and Technical Accounting to ensure that recommendations maximized benefits while complying with internal policies and external regulations.

Acted as Corporate Finance lead or co-lead on more than 20 acquisitions and divestitures representing $12B+ in deployed capital. Promoted following $2.1B acquisition of PSS World Medical. Supported Chief Financial Officer and other executives by leading strategic projects and providing analysis of competitive landscape.• Performed ad hoc financial analyses and presented recommendations to senior management; topics included share repurchases versus alternate capital deployment options, strategic alternatives for an underperforming business unit and the potential switch to adjusted earnings per share.• Established a hurdle rate framework for prospective acquisition targets to promote investment returns above the weighted average cost of capital. Achieved corporate goals by rationalizing investment criteria and protecting scarce capital; accepted by business units due to objective nature of process.• Implemented corporate portfolio management discipline based on return on invested capital, thereby enhancing investment prioritization and steering capital toward higher-yielding initiatives / business units.• Produced quarterly report package that compared McKesson's performance versus competitors and summarized key industry trends.• Counseled business units on acquisition and divestiture opportunities with a focus on valuation as well as key drivers, risks and opportunities, strategic rationale / competitive positioning and return on investment.• Analyzed sources and uses of funds to ensure availability to execute acquisitions while maintaining target capital structure and liquidity thresholds.

Tackled projects and improved processes for organization during period of rapid growth and change. Promoted from Senior Financial Analyst for ability to execute against complex deliverables under tight deadlines.• Directed initiative that produced proprietary insight into customers' wallet share and compliance. Provided analysis and strategic guidance on utilization of resulting data for new customer loyalty program.• Drove effort to set up and deploy tools for profitability reporting and analytics; primary application was improved decisions in the areas of pricing, customer / vendor relationships and profit leaks.• Developed a comprehensive model to forecast daily cash position 30 days out, incorporating data from multiple source systems. Optimized cash management by highlighting potential shortfalls and partnering with management to identify workarounds.• Represented Finance on cross-functional team that oversaw transition from drop ship model to ownership and management of $100M+ in inventory; responsibilities included project management, inventory planning, PO approval and inventory reconciliation.• Headed execution of $300M credit facility, switch to new banking institution and the integration of Treasury / cash management functions following an acquisition.

Equity research for institutional investors

Real estate investment banking